Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,170 public trials 787 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Completed

A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

NCT01891344

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 75 locations
View Trial Details
Completed

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • Hospital Haroldo Juacaba Instituto do Cancer do Ceara Fortaleza, Ceará, Brazil
  • Instituto de Oncologia do Parana (IOP) Curitiba, Paraná, Brazil
View all 77 locations
View Trial Details
Completed

A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

NCT01482715

Conditions
Adnexal Diseases, Advanced Solid Tumor With Evidence of Germline or Somatic BRCA, Disease Attributes, +22 more
Locations
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute Sarasota, Florida, United States
  • Dana-Farber Cancer Institute (Part 3 only) Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 16 locations
View Trial Details
Completed

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

NCT01968213

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 96 locations
View Trial Details
Completed

A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

NCT01847274

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 112 locations
View Trial Details
Completed

A 6 Month Safety Extension Study of MBGS205

NCT02908074

Conditions
Endocrine System Diseases, Gonadal Disorders, Hypogonadism, +1 more
Locations
  • Mereo Research Site Mobile, Alabama, United States
  • Mereo Research Site Chandler, Arizona, United States
  • Mereo Research Site Phoenix, Arizona, United States
  • Mereo Research Site Scottsdale, Arizona, United States
View all 37 locations
View Trial Details

Related conditions